is retatrutide prescription only for weight loss: Study shows 30% body weight loss Retatrutide is getting attention —

The study found people with type 2 diabetes who are receiving treatment with GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups compared to those taking DPP-4 drugs

And that's similar to cancer, actually, where you can do the genotype of an individual and identify what's the best chemotherapy or immunotherapy for an individual with, let's say, a certain kind of breast cancer

Distribution of glucagon-like peptide 1-immunopositive neurons in human caudal medulla

Amersi thinks patients can benefit from microdosing now, even without data to prove its efficacy, if they work with a doctor to carefully monitor their response

According to a recent analysis by IQVIA, first-time prescriptions for GLP-1 therapies have surged from a mere 3% of diabetes patients in 2021 to nearly 25% by early 2025

Banana, apple, spinach, or cucumber smoothies pair well with it